A critical advance in cancer study is arising with the use of nanobodies to reactivate dysfunctional p53. This vital cancer suppressor protein is frequently disabled in various forms of tumors, resulting uncontrolled https://peakbookmarks.com/story22031868/mini-antibodies-reactivate-the-p53-protein-the-potential-hope-for-malignant-therapy